search
Back to results

Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients (EMOCUIDA)

Primary Purpose

Psychological Support to Caregivers of Azlheimer's Patients

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Cognitive Behavioral Therapy Group
Sponsored by
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Psychological Support to Caregivers of Azlheimer's Patients focused on measuring Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡

Eligibility Criteria

18 Years - 95 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • To be the principal caregiver of a person with Alzheimer's disease
  • The patient has a possible or probable diagnosis of Alzheimer's disease made for an Accredited Dementia Unit.
  • The patient score in the Global Deterioration Scale must be: 4, 5 or 6A.
  • The caregiver must dedicate at least 5 hours a day or spend a significant part of his time to care-related tasks
  • The caregiver must sign the Informed Consent

Exclusion Criteria:

  • To receive a financial compensation for the care of the patient
  • The caregiver or the patient has a psychiatric illness according to the DSM-IV TR, such that the investigator considers it might hinder the dynamics of the group and affect the objectives of the study
  • Be receiving some type of formal counseling (conducted by a therapist

Sites / Locations

  • Hospital del Carme
  • Primary Assistant Center Les Corts
  • Primary Assistant Center Sarrià

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Cognitive Behavioral Therapy Group

Control Group

Arm Description

14 therapy sessions, once a week for one and a half hours.

Social support for caregiver (through the social worker) as usual. The social worker gives information when they considered that there is a social economic risk or upon request by the caregiver.

Outcomes

Primary Outcome Measures

Change from baseline in POMS Scale ("Profile of Mood States")
Change from baseline compared to the control and active arms using the Profile of Mood State (POMS) validated in structure and content for the Spanish language. This scale is a popular instrument for mood evaluation. It comprises 44 items (with a Likert response from 0 to 4), representing six conceptual dimensions: tension, depression,anger, vigour, fatigue and friendliness.

Secondary Outcome Measures

Change from baseline compared to the control and active arms using the Martin and cols. scale to assess the overload level of the family caregivers of patients with probable or possible Alzheimer's disease or other advanced stage dementia.
Martin and cols. scale is an adaptation of the Zarit questionnaire to assess the overload level of the caregiver. It is a self administered questionnaire, with 22 items with each item scored from 1 ('none') to 5 ('nearly always').

Full Information

First Posted
December 18, 2012
Last Updated
July 8, 2014
Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT01762618
Brief Title
Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients
Acronym
EMOCUIDA
Official Title
Experimental Study of the Impact of a Structured Psychological Intervention Based on Group Therapy for Caregivers of Alzheimer's Patients.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2014
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
April 2013 (Actual)
Study Completion Date
July 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
A randomized controlled trial designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 14 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can benefit from group counseling, with an improvement in mood state, quality of life, perceived burden and a decrease in anxiety and depression. Two evaluations will be done: before the therapy sessions (basal) and when intervention is finished (final).
Detailed Description
The aim of this study is to conduct group therapy with Alzheimer's caregivers at three centers in the province of Barcelona: Hospital El Carme Badalona, Sanitary Center of Les Corts and Sarrià. The therapy sessions are conducted by an expert in group therapy (from the sponsor Pasqual Maragall Foundation) and the social worker of each of the centers. The study takes place for four months and consists of weekly therapy sessions of an hour and a half each (14 sessions in total), based on cognitive and behavioral theory. The participants and the control group are evaluated at the beginning and at the end of the study in terms of mood, quality of life, anxiety and depression. This study aims to demonstrate that Alzheimer's patient's caregivers can benefit from group counseling, resulting in an improvement in their emotional state, perceived burden, quality of life and a more positive attitude coping with the new situation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychological Support to Caregivers of Azlheimer's Patients
Keywords
Group Cognitive Behavior Therapy, Alzheimer's disease, Caregivers¡

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
83 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cognitive Behavioral Therapy Group
Arm Type
Experimental
Arm Description
14 therapy sessions, once a week for one and a half hours.
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Social support for caregiver (through the social worker) as usual. The social worker gives information when they considered that there is a social economic risk or upon request by the caregiver.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Behavioral Therapy Group
Other Intervention Name(s)
14 therapy sessions, once a week for one and a half hours.
Intervention Description
Therapy Groups
Primary Outcome Measure Information:
Title
Change from baseline in POMS Scale ("Profile of Mood States")
Description
Change from baseline compared to the control and active arms using the Profile of Mood State (POMS) validated in structure and content for the Spanish language. This scale is a popular instrument for mood evaluation. It comprises 44 items (with a Likert response from 0 to 4), representing six conceptual dimensions: tension, depression,anger, vigour, fatigue and friendliness.
Time Frame
Pre-treatment and 4 weeks post treatment
Secondary Outcome Measure Information:
Title
Change from baseline compared to the control and active arms using the Martin and cols. scale to assess the overload level of the family caregivers of patients with probable or possible Alzheimer's disease or other advanced stage dementia.
Description
Martin and cols. scale is an adaptation of the Zarit questionnaire to assess the overload level of the caregiver. It is a self administered questionnaire, with 22 items with each item scored from 1 ('none') to 5 ('nearly always').
Time Frame
Pre-treatment and 4 weeks post treatment
Other Pre-specified Outcome Measures:
Title
Change from baseline compared to the control and active arms using the SF-36 v2 (Short Form-36 Health Survey), a questionnaire that measures the Quality of Life related to Health.
Description
The SF-36 has 36 items that assesse eight health concepts: limitations in physical activities because of health problems; limitations in social activities because of physical or emotional problems; limitations in usual role activities because of physical health problems); bodily pain; general mental health (psychological distress and well-being); limitations in usual role activities because of emotional problems; vitality (energy and fatigue); and general health perceptions. This version of the instrument asks for participants to reply to questions according to how they have felt over the previous four weeks. The items use Likert-type scales, some with 3, 5 or 6 points.
Time Frame
Pre-treatment and 4 weeks post treatment
Title
Change from baseline compared to the control and active arms using the Hospital Anxiety and Depression Scale (HADS)
Description
The HADS is a fourteen item scale with a Likert response from 0 to 3 that generates ordinal data. Seven of the items relate to anxiety and seven relate to depression.
Time Frame
Pre-treatment and 4 weeks post treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
95 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: To be the principal caregiver of a person with Alzheimer's disease The patient has a possible or probable diagnosis of Alzheimer's disease made for an Accredited Dementia Unit. The patient score in the Global Deterioration Scale must be: 4, 5 or 6A. The caregiver must dedicate at least 5 hours a day or spend a significant part of his time to care-related tasks The caregiver must sign the Informed Consent Exclusion Criteria: To receive a financial compensation for the care of the patient The caregiver or the patient has a psychiatric illness according to the DSM-IV TR, such that the investigator considers it might hinder the dynamics of the group and affect the objectives of the study Be receiving some type of formal counseling (conducted by a therapist
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sandra Poudevida, PhD
Organizational Affiliation
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital del Carme
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
0
Country
Spain
Facility Name
Primary Assistant Center Les Corts
City
Barcelona
State/Province
Catalonia
Country
Spain
Facility Name
Primary Assistant Center Sarrià
City
Barcelona
State/Province
Catalonia
Country
Spain

12. IPD Sharing Statement

Links:
URL
http://www.fpmaragall.org
Description
Links to Pasqual Maragall Foundation Web page

Learn more about this trial

Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients

We'll reach out to this number within 24 hrs